Quality & Compliance
Quality is at the center of every Novocol Pharma operation. The Cambridge site runs on an advanced digital QMS that integrates sterility assurance, data integrity, training, documentation, and governance into a single connected ecosystem. With a long record of positive FDA, Health Canada, and ISO outcomes, Novocol Pharma pairs rigorous systems with a culture that expects every employee to own Quality from the moment they step onto the floor.
Aseptic Filling Infrastructure Designed for Reliability and Throughput
Quality at Novocol Pharma is an interlocking system built on digital infrastructure, operational discipline, and cross-functional visibility. Electronic documentation, real-time data capture, audit trail governance, and automated reporting create a manufacturing environment where issues are identified early and resolved quickly.
The QMS is powered by a suite of validated digital platforms, including ENNOV for controlled document management, StarLIMS for QC data and environmental monitoring, Antares Vision for serialization, AX for supply chain and batch genealogy, BMRAM for asset compliance, and Yokogawa systems supporting facility and utility monitoring.
Together, these tools create a closed-loop compliance environment that provides traceability from raw materials to final packaged units while reinforcing A.L.C.O.A data integrity principles.
Regulatory governance is equally robust. The facility’s design supports contamination control, unidirectional flows, segregated air systems, and validated sterilization pathways. Daily QA presence on the floor ensures real-time decision-making and continuous process verification. These features support compliance with FDA, Health Canada, and ISO 13485 expectations.
Regulatory Inspection Outcomes and Global Standards
Novocol Pharma’s inspection history reflects years of consistent execution. For decades, the Cambridge facility has completed FDA, Health Canada, and BSI ISO 13485 audits with strong outcomes and no major regulatory observations documented in recent cycles.
These results reflect both system maturity and a quality culture that values transparency, documentation discipline, and proactive remediation. For partners, this record translates into reduced regulatory risk and higher confidence during development, validation, and commercial manufacturing.
Quality Ecosystem:
QA, QC Chemistry,
and QC Microbiology
Novocol Pharma’s Quality organization integrates large, highly credentialed teams across assurance, chemistry, and microbiology.
Quality Assurance
QA provides continuous, on-floor oversight with:
- QA auditors present on all shifts
- SOP compliance audits (~80 per year)
- AQL and batch record review
- Real-time GMP coaching and issue resolution
- CAPA, change control, deviation management, and effectiveness tracking
Quality Control Chemistry
QC Chemistry’s capabilities include:
- HPLC (13 units), UPLC, GC-FID, HPIC, ICP-OES, FTIR, viscometry, elemental impurities, nitrosamines
- Stability program oversight supported by walk-in and upright chambers
- Raw material, in-process, finished product, and component testing
- eCTD and regulatory response support
Quality Control Microbiology
QC Micro ensures sterility assurance through:
- Bioburden, endotoxin, liquid particle counts, sterility testing, PET/AET
- Environmental monitoring (viable, non-viable, passive, active, surface)
- Segregated live labs and SKAN sterility isolators
- Robust trending of water, compressed gases, and cleanroom microbiology
Together, QA, QC Chemistry, and QC Micro form a tightly connected quality engine that supports every manufacturing decision.
Media Fill and Sterility Assurance Performance
Sterility assurance is foundational to Novocol Pharma’s operations, supported by:
> 20
consecutive media fills completed since 2016
> 500,000
units filled and incubated with zero growth positive results
Comprehensive CCS integrating facility design
personnel qualification, gowning, aseptic behaviour monitoring, and component sterilization controls
A Culture and System Designed for Continuous Quality Elevation
Novocol Pharma’s cultural excellence framework, Catalyst, elevates quality from a procedural obligation to an organizational mindset. Based on ten principles grounded in ISPE’s cultural excellence model, Catalyst promotes equipment readiness, aseptic discipline, data integrity, contamination prevention, documentation accuracy, and team-based accountability. Recognition programs, coaching, and leadership visibility reinforce expectations and help strengthen right-first-time execution across all shifts.
Rather than relying solely on procedural training, Catalyst emphasizes behavioral reinforcement. Employees are encouraged to ask questions, escalate concerns, and collaborate to resolve issues quickly. QA’s active on-floor presence provides real-time coaching, bridging the gap between written expectations and daily operations.
Novocol Pharma’s QMS integrates continuous improvement activities into every operational tier. CAPA cycles are monitored for effectiveness, not just closure. Trends in deviations, environmental monitoring, equipment performance, and training completion inform targeted improvements. These insights shape SOP refinement, engineering controls, and operator training plans.
Internal audits occur throughout the year, covering SOP adherence, documentation quality, and systemic performance. Cross-functional Kaizen initiatives address waste reduction, workflow optimization, and process robustness. Quality metrics are transparent across the site, enabling teams to respond proactively to emerging risks and maintain long-term consistency.
Together, Catalyst and the continuous improvement programs create an environment where compliance is predictable, issues are resolved early, and operational maturity grows stronger with each production cycle. For clients, this means fewer deviations, smoother tech transfer, faster decision cycles, and greater reliability throughout clinical and commercial manufacturing.